Champions Oncology (CSBR) Receivables - Other (2016 - 2025)
Historic Receivables - Other for Champions Oncology (CSBR) over the last 15 years, with Q4 2025 value amounting to $7.2 million.
- Champions Oncology's Receivables - Other rose 809.47% to $7.2 million in Q4 2025 from the same period last year, while for Oct 2025 it was $7.2 million, marking a year-over-year increase of 809.47%. This contributed to the annual value of $5.4 million for FY2025, which is 913.99% down from last year.
- Latest data reveals that Champions Oncology reported Receivables - Other of $7.2 million as of Q4 2025, which was up 809.47% from $5.3 million recorded in Q3 2025.
- In the past 5 years, Champions Oncology's Receivables - Other ranged from a high of $7.2 million in Q4 2025 and a low of $3.0 million during Q2 2021
- Its 5-year average for Receivables - Other is $4.7 million, with a median of $4.3 million in 2022.
- Its Receivables - Other has fluctuated over the past 5 years, first surged by 8945.45% in 2021, then crashed by 1069.71% in 2023.
- Quarter analysis of 5 years shows Champions Oncology's Receivables - Other stood at $4.0 million in 2021, then rose by 8.14% to $4.3 million in 2022, then fell by 7.28% to $4.0 million in 2023, then skyrocketed by 65.77% to $6.6 million in 2024, then rose by 8.09% to $7.2 million in 2025.
- Its Receivables - Other was $7.2 million in Q4 2025, compared to $5.3 million in Q3 2025 and $5.4 million in Q2 2025.